{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:35:09Z","timestamp":1789403709106,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Secretar\u00eda de Ciencia, Humanidades, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["1563"],"award-info":[{"award-number":["1563"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Secretar\u00eda de Ciencia, Humanidades, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["300062"],"award-info":[{"award-number":["300062"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008688","name":"Centro de Investigaci\u00f3n y de Estudios Avanzados del Instituto Polit\u00e9cnico Nacional","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jcyt.2026.102927","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:09:04Z","timestamp":1781107744000},"page":"102927","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Isolation of adipose-derived mesenchymal stromal cells expressing soluble forms of GAS1 and PTEN for experimental cell therapy for glioblastoma"],"prefix":"10.1016","volume":"28","author":[{"given":"Gisela","family":"Tovar-Medina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Daniela","family":"Flor\u00e1n-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Arturo","family":"Avalos-Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Rodr\u00edguez-Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8215-4772","authenticated-orcid":false,"given":"Jos\u00e9","family":"Segovia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2026.102927_bib0001","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jcyt.2026.102927_bib0002","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.15252\/emmm.201302627","article-title":"Emerging treatment strategies for glioblastoma multiforme","volume":"6","author":"Carlsson","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jcyt.2026.102927_bib0003","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/ajco.12756","article-title":"Biomarkers and therapeutic advances in glioblastoma multiforme","volume":"14","author":"Sasmita","year":"2018","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.jcyt.2026.102927_bib0004","doi-asserted-by":"crossref","DOI":"10.3390\/biom11121870","article-title":"Drug repurposing for glioblastoma and current advances in drug delivery\u2014a comprehensive review of the literature","volume":"11","author":"Alomari","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.jcyt.2026.102927_bib0005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1039\/D4PM00263F","article-title":"Comprehensive review on glioblastoma: nanotechnology, immunotherapy and combined therapeutic approaches","volume":"2","author":"Dhiman","year":"2025","journal-title":"RSC Pharm"},{"key":"10.1016\/j.jcyt.2026.102927_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12122664","article-title":"Predictive and prognostic significance of molecular biomarkers in glioblastoma","volume":"12","author":"Shah","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.jcyt.2026.102927_bib0007","doi-asserted-by":"crossref","DOI":"10.1007\/s10143-025-03647-2","article-title":"Socioeconomic status as a determinant of survival in glioblastoma: a systematic review and meta-analysis","volume":"48","author":"Wijaya","year":"2025","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.jcyt.2026.102927_bib0008","series-title":"Glioblastoma","article-title":"Current standards of care in glioblastoma therapy","author":"Fernandes","year":"2017"},{"key":"10.1016\/j.jcyt.2026.102927_bib0009","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0092-8674(00)81692-X","article-title":"Stem cells: units of development, units of regeneration, and units in evolution","volume":"100","author":"Weissman","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.jcyt.2026.102927_bib0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3892\/ol.2015.3860","article-title":"Use of genetically engineered stem cells for glioma therapy","volume":"11","author":"Namba","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jcyt.2026.102927_bib0011","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000469686","article-title":"Stem cell therapy of gliomas","volume":"32","author":"Kerrigan","year":"2018","journal-title":"Prog Neurol Surg"},{"key":"10.1016\/j.jcyt.2026.102927_bib0012","first-page":"1307","article-title":"Mesenchymal stem cells in cancer therapy; the art of harnessing a foe to a friend","volume":"24","author":"Karimi-Shahri","year":"2021","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.jcyt.2026.102927_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-018-0977-z","article-title":"Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas","volume":"9","author":"Zhang","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2026.102927_bib0014","doi-asserted-by":"crossref","first-page":"30015","DOI":"10.3390\/ijms161226215","article-title":"Mesenchymal stem cell-mediated effects of tumor support or suppression","volume":"16","author":"Rhee","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcyt.2026.102927_bib0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.arr.2010.08.005","article-title":"MSCs: biological characteristics, clinical applications and their outstanding concerns","volume":"10","author":"Si","year":"2011","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.jcyt.2026.102927_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fbioe.2020.00043","article-title":"Therapeutic potential of mesenchymal stem cells for cancer therapy","volume":"8","author":"Hmadcha","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"issue":"2","key":"10.1016\/j.jcyt.2026.102927_bib0017","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tips.2005.12.004","article-title":"Is GAS1 a co-receptor for the GDNF family of ligands?","volume":"27","author":"Schueler-Furman","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jcyt.2026.102927_bib0018","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.nbd.2003.11.022","article-title":"Glial-specific retrovirally mediated gas1 gene expression induces glioma cell apoptosis and inhibits tumor growth in vivo","volume":"15","author":"Zamorano","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jcyt.2026.102927_bib0019","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10495-011-0696-8","article-title":"GAS1 induces cell death through an intrinsic apoptotic pathway","volume":"17","author":"Zarco","year":"2012","journal-title":"Apoptosis"},{"key":"10.1016\/j.jcyt.2026.102927_bib0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.20517\/2394-4722.2015.76","article-title":"Effects of Gas1 on gliomas: a review on current preclinical studies","volume":"2","author":"Segovia","year":"2016","journal-title":"J Cancer Metastasis Treat"},{"key":"10.1016\/j.jcyt.2026.102927_bib0021","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jcyt.2013.12.004","article-title":"Neural stem cells producing an inducible and soluble form of Gas1 target and inhibit intracranial glioma growth","volume":"16","author":"L\u00f3pez-Ornelas","year":"2014","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2026.102927_bib0022","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.yexcr.2014.06.016","article-title":"A soluble form of GAS1 inhibits tumor growth and angiogenesis in a triple negative breast cancer model","volume":"327","author":"Jim\u00e9nez","year":"2014","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jcyt.2026.102927_bib0023","doi-asserted-by":"crossref","unstructured":"Hopkins BD, Fine B, Steinbach N, Dendy M, Rapp Z, Shaw J, et al. A secreted PTEN phosphatase that enters cells to alter signaling and survival 2013;341:399\u2013403.","DOI":"10.1126\/science.1234907"},{"issue":"4","key":"10.1016\/j.jcyt.2026.102927_bib0024","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.tibs.2014.02.006","article-title":"PTEN function: the long and the short of it","volume":"39","author":"Hopkins","year":"2014","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.jcyt.2026.102927_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2018.00338","article-title":"PTEN: tumor suppressor and metabolic regulator","volume":"9","author":"Chen","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcyt.2026.102927_bib0026","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1042\/BJ20150931","article-title":"The intrinsically disordered tails of PTEN and PTEN-L have distinct roles in regulating substrate specificity and membrane activity","volume":"473","author":"Masson","year":"2015","journal-title":"Biochem J"},{"issue":"6144","key":"10.1016\/j.jcyt.2026.102927_bib0027","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1126\/science.1242541","article-title":"Cell biology: Where is PTEN?","volume":"341","author":"Leslie","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jcyt.2026.102927_bib0028","first-page":"1","article-title":"Relevance and therapeutic possibility of PTEN-Long in renal cell carcinoma","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jcyt.2026.102927_bib0029","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41434-018-0020-0","article-title":"Additive effects of the combined expression of soluble forms of GAS1 and PTEN inhibiting glioblastoma growth","volume":"25","author":"S\u00e1nchez-Hern\u00e1ndez","year":"2018","journal-title":"Gene Ther"},{"key":"10.1016\/j.jcyt.2026.102927_bib0030","doi-asserted-by":"crossref","first-page":"11769","DOI":"10.2147\/OTT.S260671","article-title":"Simultaneous treatment with soluble forms of GAS1 and PTEN reduces invasiveness and induces death of pancreatic cancer cells","volume":"13","author":"Daniel-Garc\u00eda","year":"2020","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.jcyt.2026.102927_bib0031","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jcyt.2020.09.011","article-title":"The systemic administration of neural stem cells expressing an inducible and soluble form of growth arrest specific 1 inhibits mammary gland tumor growth and the formation of metastases","volume":"23","author":"Romero-Trejo","year":"2021","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2026.102927_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21769\/BioProtoc.2516","article-title":"Isolation and expansion of mesenchymal stem cells from murine adipose tissue","volume":"7","author":"Andreeva","year":"2017","journal-title":"Bio-Protocol"},{"key":"10.1016\/j.jcyt.2026.102927_bib0033","series-title":"The Mouse Brain in Stereotaxic Coordinates","volume":"360","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.jcyt.2026.102927_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100290","article-title":"Intranasal delivery of experimental compounds in orthotopic brain tumor mouse models","volume":"2","author":"Eyme","year":"2021","journal-title":"STAR Protoc"},{"key":"10.1016\/j.jcyt.2026.102927_bib0035","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/14653240500319234","article-title":"Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement","volume":"7","author":"Horwitz","year":"2005","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2026.102927_bib0036","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2026.102927_bib0037","first-page":"2613","article-title":"Survival analysis of glioblastoma multiforme","volume":"19","author":"Witthayanuwat","year":"2018","journal-title":"Asian Pacific J Cancer Prev"},{"key":"10.1016\/j.jcyt.2026.102927_bib0038","doi-asserted-by":"crossref","first-page":"61","DOI":"10.17691\/stm2023.15.3.07","article-title":"Personalized medicine in brain gliomas: targeted therapy, patient-derived tumor models (review)","volume":"15","author":"Yashin","year":"2023","journal-title":"Sovrem Tehnol v Med"},{"key":"10.1016\/j.jcyt.2026.102927_bib0039","doi-asserted-by":"crossref","first-page":"12846","DOI":"10.1073\/pnas.97.23.12846","article-title":"Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas","volume":"97","author":"Aboody","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jcyt.2026.102927_bib0040","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/74710","article-title":"Gene therapy of experimental brain tumors using","volume":"6","author":"Benedetti","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2026.102927_bib0041","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1038\/onc.2010.75","article-title":"Human stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumors","author":"Van Eekelen","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.jcyt.2026.102927_bib0042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060655","article-title":"Transmigration of neural stem cells across the blood brain barrier induced by glioma cells","volume":"8","author":"D\u00edaz-Cor\u00e1nguez","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jcyt.2026.102927_bib0043","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jcyt.2026.102927_bib0044","doi-asserted-by":"crossref","unstructured":"Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S Generation of mouse induced pluripotent stem cells without viral vectors 2008;322:949\u201353.","DOI":"10.1126\/science.1164270"},{"key":"10.1016\/j.jcyt.2026.102927_bib0045","first-page":"eaah6510","article-title":"Tumor-homing cytotoxic human induced neural stem cells for cancer therapy","volume":"6510","author":"Okolie","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jcyt.2026.102927_bib0046","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11020595","article-title":"Mesenchymal stem cells genetically modified by lentivirus-express soluble TRAIL and interleukin-12 inhibit growth and reduced metastasis-relate changes in lymphoma mice model","volume":"11","author":"Quiroz-Reyes","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jcyt.2026.102927_bib0047","first-page":"6","article-title":"Mesenchymal stem cells as delivery vectors for anti-tumor therapy","volume":"2","author":"Li","year":"2015","journal-title":"Stem Cell Investig"},{"key":"10.1016\/j.jcyt.2026.102927_bib0048","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1158\/0008-5472.CAN-04-1874","article-title":"Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas","volume":"65","author":"Nakamizo","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcyt.2026.102927_bib0049","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jcyt.2012.10.003","article-title":"Tumor stroma engraftment of gene-modified mesenchymal stem cells as anti-tumor therapy against ovarian cancer","volume":"15","author":"Dembinski","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2026.102927_bib0050","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1002\/ijc.30402","article-title":"TRAIL delivered by mesenchymal stromal\/stem cells counteracts tumor development in orthotopic Ewing sarcoma models","volume":"139","author":"Guiho","year":"2016","journal-title":"Int J Cancer"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324926008881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324926008881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:23:28Z","timestamp":1788362608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324926008881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1465324926008881"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2026.102927","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isolation of adipose-derived mesenchymal stromal cells expressing soluble forms of GAS1 and PTEN for experimental cell therapy for glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2026.102927","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society for Cell & Gene Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102927"}}